Please assess the completion status of the following clinical trial:

Trial Title: Comparative Evaluation of Herbal and Allopathic Drugs for the Treatment of Chronic Diarrhea

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female adults between the age of 18-60 years who were suffering from diarrhea of presumed infectious origin and willing to participate were eligible for inclusion in the study.~Exclusion Criteria:~* Exclusion criteria were the presence of chronic~* Iatrogenic, or bloody diarrhea, having received antibiotic treatment for other medical or surgical problems~* Having a history of renal or hepatic dysfunction~* Having a concomitant infection.~* Patients receiving treatment with an anti-diarrheal drug in the five days prior to the study were also excluded.~* Pregnant or lactating women and women planning pregnancy were also ineligible for study participation.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- Entoban Capsules (Type: EXPERIMENTAL): Entoban is the combination of Holarrhena antidysenterica, Berberis aristata, Symplocos racemosa, Querecus infectoria and Helicteres isora.
- Metronidazole DS (Type: EXPERIMENTAL): Metronidazole DS(400 mg) is commonly used to treat diarrhea.It eliminates bacteria and other microorganisms that cause infections of the reproductive system, gastrointestinal tract, skin, vagina, and other areas of the body.

Based on this trial design, predict the completion outcome and termination type (if applicable).